Celsius Holdings
CELH · NASDAQ
About CELH
- Employees
- 1,497
- Headquarters
- Boca Raton, Florida
- Listed
- Oct 10, 2006
- Sector
- Consumer Staples
- Industry
- Beverages
- Website
- celsiusholdingsinc.com
CELH key statistics
- Market cap
- 7.58B
- Price-earnings ratio
- 129.22
- Dividend yield
- 0.69%
- Average volume
- 5.88M
- Volume
- 4.54M
- Open price
- $29.72
- High today
- $30.21
- Low today
- $29.50
- 52 Week high
- $66.00
- 52 Week low
- $23.56
Celsius Holdings (CELH) at a glance
As of Oct 20, 2026, Celsius Holdings (CELH) shares are priced at $29.96, giving the company a market cap of 7.58B, a price-to-earnings ratio of 129.22 and a dividend yield of 0.69%.
Today the stock has traded between $29.50 and $30.21. The current price is 1.6% above the day's low and 0.8% below its high.
Volume so far is 4.54M shares, below the average of 5.88M shares a day.
Over the past year Celsius Holdings has ranged from $23.56 to $66.00, and now sits 15% of the way up that range.
Celsius Holdings met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.36 per share against an estimate of $0.4335.
The average analyst price target is $42.68, 42.4% above the current price, from 17 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy76.5%
- Hold23.5%
- Sell0.0%
- Low
- $26.26
- Now
- $29.96
- High
- $67.20
CELH earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 50.4% on average.
- Q3 FY24: reported $0.00 per share against an estimate of $0.0281
- Q4 FY24: reported -$0.11 per share against an estimate of $0.1116
- Q1 FY25: reported $0.18 per share against an estimate of $0.1971
- Q2 FY25: reported $0.47 per share against an estimate of $0.2431
- Q3 FY25: reported $0.42 per share against an estimate of $0.2815
- Q4 FY25: reported $0.26 per share against an estimate of $0.2103
- Q1 FY26: reported $0.41 per share against an estimate of $0.3025
- Q2 FY26: reported $0.36 per share against an estimate of $0.4335
CELH news
- Press releasePRNewswire
- Evette Mitkov
Celsius Stock Pops: What's Going On?
- Press releasePRNewswire
CELH Deadline: CELH Investors Have Opportunity to Lead Celsius Holdings, Inc. Securities Fraud Lawsuit
- Press releaseGlobe Newswire
Celsius Holdings, Inc. Class Action Reminder - Robbins LLP Encourages CELH Investors to Contact the Firm for Information About Their Rights
- Press releasePRNewswire
Celsius Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CELH
- Press releaseGlobe Newswire
Pomerantz Law Firm Announces The Filing of a Class Action Against Celsius Holdings, Inc. and Certain Officers – CELH
- Press releasePRNewswire
CELH Investors Have Opportunity to Lead Celsius Holdings, Inc. Securities Fraud Lawsuit with SBS Law
- Press releasePRNewswire
Pomerantz Law Firm Announces The Filing of a Class Action Against Celsius Holdings, Inc. and Certain Officers - CELH
Similar companies
Companies in the same industry as Celsius Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.